Skip to main content
. 2021 Aug 11;2021:9990091. doi: 10.1155/2021/9990091

Table 4.

Histopathological scores of liver lesions in the normal control, diclofenac-injected group, and diclofenac-injected groups treated with naringin, hesperidin, and their combination.

Histopathological changes Score Normal control Diclofenac Diclofenac+naringin Diclofenac+hesperidin Diclofenac+naringin+hesperidin
Hydropic and vacuolar degeneration 0 6 (100%) 1 (16.7%) 3 (50.0%) 2 (33.3%) 4 (66.7%)
I 1 (16.7%) 2 (33.3%) 2 (33.3%) 2 (33.3%)
II 2 (33.3%) 1 (16.7%) 2 (33.3%)
III 2 (33.3%)
Inflammation (inflammatory cell infiltration) 0 6 (100%) 3 (50.0%) 3 (50.0%) 5 (83.3%)
I 1 (16.7%) 1 (16.7%) 2 (33.3%) 1 (16.7%)
II 2 (33.3%) 2 (33.3%) 1 (16.7%)
III 3 (50.0%)
Necrosis 0 6 (100%) 1 (16.7%) 2 (33.3%) 4 (66.7%)
I 2 (33.3%) 2 (33.3%) 3 (50.0%) 2 (33.3%)
II 2 (33.3%) 3 (50.0%) 1 (16.7%)
III 2 (33.3%)
Apoptosis 0 6 (100%) 3 (50.0%) 3 (50.0%) 4 (66.7%)
I 1 (16.7%) 3 (50.0%) 2 (33.3%) 1 (16.7%)
II 2 (33.3%) 1 (16.7%)- 1 (16.7%)
III 3 (50.0%)
Kupffer cell proliferation 0 6 (100%) 3 (50.0%) 3 (50.0%) 4 (66.7%)
I 1 (16.7%) 1 (16.7%) 2 (33.3%) 1 (16.7%)
II 3 (50.0%) 2 (33.3%) 1 (16.7%) 1 (16.7%)
III 2 (33.3%)
Fatty changes and steatosis 0 6 (100%) 4 (66.7%) 4 (66.7%) 4 (66.7%) 6 (100%)
I 1 (16.7%) 1 (16.7%)
II 1 (16.7%) 1 (16.7%) 2 (33.3%)
III
Congested blood vessels and sinusoids 0 6 (100%) 3 (50.0%) 4 (66.7%) 4 (66.7%)
I 2 (33.3%) 1 (16.7%) 2 (33.3%)
II 3 (50.0%) 2 (33.3%) 1 (16.7%)
III 1 (16.7%) 1 (16.7%)
Hyperplasia of epithelial lining of the bile duct 0 6 (100%) 4 (66.7%) 5 (83.3%) 6 (100%) 6 (100%)
I
II 1 (16.7%)
III 2 (33.3%)

0: absence of lesion; I: mild; II: moderate; III: severe. Number of animals in each group is 6. Numbers 1, 2, 3, 4, 5, and 6 represent the number of animals for each grade. The % in parentheses is the percent of animals in each grade.